Basis: Latest stored market observation. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 1.45x is in line with its 1-year average of 1.57x, near the low end of its 1-year range (1.30x–1.87x).
As of Sunday, July 26, 2026.
EV/SALES RATIO
1.45x
EV/SALES RATIO AVG TTM
N/A
EV/SALES RATIO AVG 3Y
N/A
EV/SALES RATIO AVG 5Y
N/A
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.66x
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-60.38%
vs the sector median at left
Market Cap
$36.28B
EV/Sales Ratio
8.66x
TTM Avg
16.11x
3Y Avg
15.57x
5Y Avg
19.72x
Market Cap
$27.56B
EV/Sales Ratio
1.80x
TTM Avg
2.03x
3Y Avg
2.17x
5Y Avg
2.19x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medline Inc. (MDLN) | $32.77B | 1.45x | N/A | N/A | N/A |
| Zoetis Inc. (ZTS)vs › | $31.59B | 4.11x | 6.25x | 8.54x | 9.67x |
| Centene Corp. (CNC)vs › | $31.31B | 0.13x | 0.11x | 0.20x | 0.28x |
| IQVIA Holdings Inc. (IQV)vs › | $34.72B | 2.97x | 2.94x | 3.22x | 3.50x |
| Biogen Inc. (BIIB)vs › | $29.85B | 3.37x | 2.91x | 3.26x | 3.54x |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $36.28B | 8.66x | 16.11x | 15.57x | 19.72x |
| ResMed Inc. (RMD)vs › | $28.33B | 5.04x | 6.64x | 6.73x | 8.03x |
| DexCom, Inc. (DXCM)vs › | $27.61B | 5.90x | 6.33x | 9.75x | 13.48x |
| GE HealthCare Technologies Inc. (GEHC)vs › | $27.56B | 1.80x | 2.03x | 2.17x | 2.19x |
| Mettler-Toledo International Inc. (MTD)vs › | $26.82B | 7.11x | 7.32x | 7.47x | 8.08x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-07-24 | 1.45x |
| 2026-07-23 | 1.42x |
| 2026-07-22 | 1.41x |
| 2026-07-21 | 1.46x |
| 2026-07-20 | 1.46x |
| 2026-07-17 | 1.48x |
| 2026-07-16 | 1.52x |
| 2026-07-15 | 1.47x |
| 2026-07-14 | 1.45x |
| 2026-07-13 | 1.51x |
| 2026-07-10 | 1.52x |
| 2026-07-09 | 1.51x |
| 2026-07-08 | 1.50x |
| 2026-07-07 | 1.57x |
| 2026-07-06 | 1.57x |
| 2026-07-02 | 1.58x |
| 2026-07-01 | 1.54x |
| 2026-06-30 | 1.47x |
| 2026-06-29 | 1.48x |
| 2026-06-26 | 1.46x |
| 2026-06-25 | 1.43x |
| 2026-06-24 | 1.38x |
| 2026-06-23 | 1.36x |
| 2026-06-22 | 1.34x |
| 2026-06-18 | 1.37x |
| 2026-06-17 | 1.39x |
| 2026-06-16 | 1.41x |
| 2026-06-15 | 1.41x |
| 2026-06-12 | 1.39x |
| 2026-06-11 | 1.41x |
| 2026-06-10 | 1.39x |
| 2026-06-09 | 1.38x |
| 2026-06-08 | 1.31x |
| 2026-06-05 | 1.31x |
| 2026-06-04 | 1.33x |
| 2026-06-03 | 1.33x |
| 2026-06-02 | 1.30x |
| 2026-06-01 | 1.37x |
| 2026-05-29 | 1.39x |
| 2026-05-28 | 1.40x |
| 2026-05-27 | 1.37x |
| 2026-05-26 | 1.38x |
| 2026-05-22 | 1.40x |
| 2026-05-21 | 1.41x |
| 2026-05-20 | 1.38x |
| 2026-05-19 | 1.42x |
| 2026-05-18 | 1.38x |
| 2026-05-15 | 1.38x |
| 2026-05-14 | 1.46x |
| 2026-05-13 | 1.45x |
| 2026-05-12 | 1.45x |
| 2026-05-11 | 1.47x |
| 2026-05-08 | 1.48x |
| 2026-05-07 | 1.54x |
| 2026-05-06 | 1.55x |
| 2026-05-05 | 1.64x |
| 2026-05-04 | 1.61x |
| 2026-05-01 | 1.62x |
| 2026-04-30 | 1.62x |
| 2026-04-29 | 1.59x |
| 2026-04-28 | 1.61x |
| 2026-04-27 | 1.64x |
| 2026-04-24 | 1.62x |
| 2026-04-23 | 1.67x |
| 2026-04-22 | 1.69x |
| 2026-04-21 | 1.70x |
| 2026-04-20 | 1.72x |
| 2026-04-17 | 1.71x |
| 2026-04-16 | 1.69x |
| 2026-04-15 | 1.71x |
| 2026-04-14 | 1.71x |
| 2026-04-13 | 1.69x |
| 2026-04-10 | 1.65x |
| 2026-04-09 | 1.65x |
| 2026-04-08 | 1.61x |
| 2026-04-07 | 1.58x |
| 2026-04-06 | 1.60x |
| 2026-04-02 | 1.61x |
| 2026-04-01 | 1.60x |
| 2026-03-31 | 1.62x |
| 2026-03-30 | 1.56x |
| 2026-03-27 | 1.55x |
| 2026-03-26 | 1.58x |
| 2026-03-25 | 1.59x |
| 2026-03-24 | 1.57x |
| 2026-03-23 | 1.59x |
| 2026-03-20 | 1.59x |
| 2026-03-19 | 1.62x |
| 2026-03-18 | 1.58x |
| 2026-03-17 | 1.58x |
| 2026-03-16 | 1.57x |
| 2026-03-13 | 1.56x |
| 2026-03-12 | 1.55x |
| 2026-03-11 | 1.58x |
| 2026-03-10 | 1.60x |
| 2026-03-09 | 1.61x |
| 2026-03-06 | 1.63x |
| 2026-03-05 | 1.63x |
| 2026-03-04 | 1.60x |
| 2026-03-03 | 1.64x |
| 2026-03-02 | 1.68x |
| 2026-02-27 | 1.73x |
| 2026-02-26 | 1.77x |
| 2026-02-25 | 1.75x |
| 2026-02-24 | 1.80x |
| 2026-02-23 | 1.79x |
| 2026-02-20 | 1.80x |
| 2026-02-19 | 1.73x |
| 2026-02-18 | 1.74x |
| 2026-02-17 | 1.69x |
| 2026-02-13 | 1.65x |
| 2026-02-12 | 1.65x |
| 2026-02-11 | 1.66x |
| 2026-02-10 | 1.67x |
| 2026-02-09 | 1.73x |
| 2026-02-06 | 1.72x |
| 2026-02-05 | 1.69x |
| 2026-02-04 | 1.66x |
| 2026-02-03 | 1.65x |
| 2026-02-02 | 1.66x |
| 2026-01-30 | 1.64x |
| 2026-01-29 | 1.62x |
| 2026-01-28 | 1.64x |
| 2026-01-27 | 1.70x |
| 2026-01-26 | 1.65x |
| 2026-01-23 | 1.69x |
| 2026-01-22 | 1.69x |
| 2026-01-21 | 1.61x |
| 2026-01-20 | 1.63x |
| 2026-01-16 | 1.63x |
| 2026-01-15 | 1.59x |
| 2026-01-14 | 1.61x |
| 2026-01-13 | 1.60x |
| 2026-01-12 | 1.59x |
| 2026-01-09 | 1.53x |
| 2026-01-08 | 1.55x |
| 2026-01-07 | 1.53x |
| 2026-01-06 | 1.51x |
| 2026-01-05 | 1.49x |
| 2026-01-02 | 1.53x |
| 2025-12-31 | 1.57x |
| 2025-12-30 | 1.80x |
| 2025-12-29 | 1.80x |
| 2025-12-26 | 1.87x |
| 2025-12-24 | 1.87x |
| 2025-12-23 | 1.85x |
| 2025-12-22 | 1.81x |
| 2025-12-19 | 1.79x |
| 2025-12-18 | 1.73x |
| 2025-12-17 | 1.77x |
